Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-17-012926
Filing Date
2017-05-11
Accepted
2017-05-11 20:26:21
Documents
2
Period of Report
2017-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 2205
2 EX-24 DOCUMENT attachment1.htm EX-24 4168
  Complete submission text file 0000899243-17-012926.txt   7918
Mailing Address 12790 EL CAMINO REAL C/O NEUROCRINE BIOSCIENCES SAN DIEGO CA 92130
Business Address
LYONS GARY A (Reporting) CIK: 0001123343 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-36620 | Film No.: 17836081

Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Issuer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations